Global provider of medical systems, Maquet, has launched a new retractor that could maximise cardiothoracic access during minimally invasive revascularisation procedures.
The new MIRA-i CS retractor system is designed to improve the visibility through the smallest of incisions, thereby avoiding the need for sternotomy with its associated risks and complications, claimed Maquet Medical Systems USA and Maquet Cardiovascular while announcing the launch.
Featuring titanium internal mammary artery (IMA) blades as well as aluminum thoracotomy blades, the retractor offers compatibility with diagnostic imaging during hybrid PCI-CABG procedures.
Using its unique pivot system to allow blades to deflect up to 30 degrees, the device will improve visibility and instrument maneuverability, avoiding any need to increase the incision length.
The company also claims that the interchangeable blades reduce workplace interference as well as provide surgeons with ergonomic experience.
Maquet Medical Systems USA president and chief executive officer Raoul Quintero said the new system is a key addition to the company's cardiac surgery offering, with the potential to help physicians improve their practice and let patients return to their normal daily routine faster.
"The use of the MIRA-i CS Retractor during revascularisation procedures may reduce post-operative discomfort and lead to a shorter recovery process, faster healing, fewer infections and less scarring for patients," Quintero said.
Maquet Cardiovascular president and chief executive officer Christian Keller said; "This product, similar to others in our cardiac surgery portfolio, provides physicians additional options to perform high-quality, minimally invasive procedures on patients"..
Image: The new retractor system is designed to offer physicians additional options to perform high-quality, minimally invasive procedures on patients. Photo: Courtesy of Maquet.